Explore
Gynaecological Cancers Risk
0 Ungluers have
Faved this Work
Login to Fave
The International Agency for Research on Cancer suggests that the burden of women’s cancers including breast, ovarian, and womb will rise by 50% over the next 20 years. It is essential for us to improve early diagnosis and prevention of these cancers in our health systems. The last decade has seen significant strides in our ability to understand and predict a woman’s risk of these cancers and offer personalized medicine approaches for risk management. There have been improvements in identifying individuals at increased risk, as well as implementing and evaluating strategies for screening and prevention. In this special collection, we bring together 16 articles from leading scientists and researchers. These capture some of the important advances observed in estimating cancer risk, providing genetic testing, offering risk management to those at increased risk, as well as screening and prevention of breast, ovarian, and womb cancers in women. This makes an important contribution to the rapidly advancing knowledge base across the area of personalized medicine and precision prevention of ovarian, endometrial, and breast cancers.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 125 times via unglue.it ebook links.
- 125 - pdf (CC BY) at Unglue.it.
Keywords
- age of pregnancy
- artificial intelligence
- Attitudes
- BMI
- body mass index
- BRCA
- BRCA1
- BRCA2
- Breast cancer
- breast cancer prevention
- breast cancer risk
- BRIP1
- CA125
- cancer prevention
- cost-effectiveness
- diagnostic prediction model
- DKC1
- dyskerin
- early BMI
- early detection
- endometrial cancer
- familial cancer
- family history
- galectin-7
- galectin-8
- galectins
- Genes
- Genetic Testing
- genomic sequencing
- Genomics
- germline
- HE4
- hereditary cancer genes
- incidence-based mortality
- Liquid Biopsy
- mammographic density
- mammography
- Mass Spectrometry
- medicine
- Medicine: General Issues
- menopausal hormone therapy
- metabolomics
- mismatch repair
- MMT
- n/a
- Obesity
- ovarian cancer
- ovarian cancer risk
- ovarian cancer symptoms
- plasma biomarkers
- population genetic testing
- population testing
- postmenopausal women
- premenopausal
- Prevention
- prognostic markers
- proliferation
- Public health & preventive medicine
- questionnaires
- RAD51C
- RAD51D
- randomised controlled trial
- rare germline variants
- Risk
- Risk assessment
- risk modelling
- risk stratification
- screening
- SNP
- Somatic
- susceptibility genes
- symptoms
- telomerase
- telomeres
- triage tool
- trial
- tumor infiltrating macrophages
- tumor mutational signatures
- TVS
- UKCTOCS
- ultrasound
- Weight loss
Links
DOI: 10.3390/books978-3-0365-2983-7Editions